miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
Abstract Carcinoma of the prostate is the most common cancer in men. Treatment of aggressive prostate cancer involves a regiment of radical prostectomy, radiation therapy, chemotherapy and hormonal therapy. Despite significant improvements in the last decade, the treatment of prostate cancer remains...
Guardado en:
Autores principales: | Noushin Nabavi, Nur Ridzwan Nur Saidy, Erik Venalainen, Anne Haegert, Abhijit Parolia, Hui Xue, Yuwei Wang, Rebecca Wu, Xin Dong, Colin Collins, Francesco Crea, Yuzhuo Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30400add8b0940e997d768e861520881 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Shangwei Zhong, et al.
Publicado: (2021) -
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021) -
Castration-resistant prostate cancer: potential targets and therapies
por: Parray A, et al.
Publicado: (2012) -
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
por: Jingsong Zhang, et al.
Publicado: (2017) -
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
por: Akash K. Kaushik, et al.
Publicado: (2016)